Regulatory, financial and ethical aspects of routine clinical magnetic resonance spectroscopy.
After years of technological development, magnetic resonance spectroscopy (MRS) is now being used with increasing frequency as a routine diagnostic tool for medical evaluation of patients. The transition of MRS from the realm of pure research to that of routine clinical application has been accompanied by some confusion regarding regulatory, financial and ethical matters. This contribution summarizes these issues from the author's perspective and calls for increased discussion and learning within the MRS community regarding practical matters associated with routine clinical implementation of MRS.